img

Global Pentavalent Antimonials Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pentavalent Antimonials Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Pentavalent Antimonials, also called pentavalent antimony compounds, are used to treat patients with leishmaniasis, but they have collateral effects and, in some cases, low cure rate. The compounds currently available for clinical use aresodium stibogluconate and meglumine antimoniate. Pentavalent antimonials can only be given by injection.
The global Pentavalent Antimonials market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Pentavalent Antimonials is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Pentavalent Antimonials is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Pentavalent Antimonials is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Pentavalent Antimonials include Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Maiden Pharmaceuticals, Xinhua Pharm, Albert David and Science Direct, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Pentavalent Antimonials, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Pentavalent Antimonials by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Pentavalent Antimonials market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Pentavalent Antimonials market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Sanofi
GlaxoSmithKline
Bristol-Myers Squibb
Maiden Pharmaceuticals
Xinhua Pharm
Albert David
Science Direct
By Type
Sodium Stibogluconate
Meglumine Antimoniate
By Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Pentavalent Antimonials in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Pentavalent Antimonials manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pentavalent Antimonials sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Pentavalent Antimonials Definition
1.2 Market by Type
1.2.1 Global Pentavalent Antimonials Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Sodium Stibogluconate
1.2.3 Meglumine Antimoniate
1.3 Market Segment by Application
1.3.1 Global Pentavalent Antimonials Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Pentavalent Antimonials Sales
2.1 Global Pentavalent Antimonials Revenue Estimates and Forecasts 2018-2034
2.2 Global Pentavalent Antimonials Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Pentavalent Antimonials Revenue by Region
2.3.1 Global Pentavalent Antimonials Revenue by Region (2018-2024)
2.3.2 Global Pentavalent Antimonials Revenue by Region (2024-2034)
2.4 Global Pentavalent Antimonials Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Pentavalent Antimonials Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Pentavalent Antimonials Sales Quantity by Region
2.6.1 Global Pentavalent Antimonials Sales Quantity by Region (2018-2024)
2.6.2 Global Pentavalent Antimonials Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Pentavalent Antimonials Sales Quantity by Manufacturers
3.1.1 Global Pentavalent Antimonials Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Pentavalent Antimonials Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Pentavalent Antimonials Sales in 2022
3.2 Global Pentavalent Antimonials Revenue by Manufacturers
3.2.1 Global Pentavalent Antimonials Revenue by Manufacturers (2018-2024)
3.2.2 Global Pentavalent Antimonials Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pentavalent Antimonials Revenue in 2022
3.3 Global Pentavalent Antimonials Sales Price by Manufacturers
3.4 Global Key Players of Pentavalent Antimonials, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pentavalent Antimonials, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pentavalent Antimonials, Product Offered and Application
3.8 Global Key Manufacturers of Pentavalent Antimonials, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Pentavalent Antimonials Sales Quantity by Type
4.1.1 Global Pentavalent Antimonials Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Pentavalent Antimonials Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Pentavalent Antimonials Sales Quantity Market Share by Type (2018-2034)
4.2 Global Pentavalent Antimonials Revenue by Type
4.2.1 Global Pentavalent Antimonials Historical Revenue by Type (2018-2024)
4.2.2 Global Pentavalent Antimonials Forecasted Revenue by Type (2024-2034)
4.2.3 Global Pentavalent Antimonials Revenue Market Share by Type (2018-2034)
4.3 Global Pentavalent Antimonials Price by Type
4.3.1 Global Pentavalent Antimonials Price by Type (2018-2024)
4.3.2 Global Pentavalent Antimonials Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Pentavalent Antimonials Sales Quantity by Application
5.1.1 Global Pentavalent Antimonials Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Pentavalent Antimonials Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Pentavalent Antimonials Sales Quantity Market Share by Application (2018-2034)
5.2 Global Pentavalent Antimonials Revenue by Application
5.2.1 Global Pentavalent Antimonials Historical Revenue by Application (2018-2024)
5.2.2 Global Pentavalent Antimonials Forecasted Revenue by Application (2024-2034)
5.2.3 Global Pentavalent Antimonials Revenue Market Share by Application (2018-2034)
5.3 Global Pentavalent Antimonials Price by Application
5.3.1 Global Pentavalent Antimonials Price by Application (2018-2024)
5.3.2 Global Pentavalent Antimonials Price Forecast by Application (2024-2034)
6 North America
6.1 North America Pentavalent Antimonials Sales by Company
6.1.1 North America Pentavalent Antimonials Revenue by Company (2018-2024)
6.1.2 North America Pentavalent Antimonials Sales Quantity by Company (2018-2024)
6.2 North America Pentavalent Antimonials Market Size by Type
6.2.1 North America Pentavalent Antimonials Sales Quantity by Type (2018-2034)
6.2.2 North America Pentavalent Antimonials Revenue by Type (2018-2034)
6.3 North America Pentavalent Antimonials Market Size by Application
6.3.1 North America Pentavalent Antimonials Sales Quantity by Application (2018-2034)
6.3.2 North America Pentavalent Antimonials Revenue by Application (2018-2034)
6.4 North America Pentavalent Antimonials Market Size by Country
6.4.1 North America Pentavalent Antimonials Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Pentavalent Antimonials Revenue by Country (2018-2034)
6.4.3 North America Pentavalent Antimonials Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pentavalent Antimonials Sales by Company
7.1.1 Europe Pentavalent Antimonials Sales Quantity by Company (2018-2024)
7.1.2 Europe Pentavalent Antimonials Revenue by Company (2018-2024)
7.2 Europe Pentavalent Antimonials Market Size by Type
7.2.1 Europe Pentavalent Antimonials Sales Quantity by Type (2018-2034)
7.2.2 Europe Pentavalent Antimonials Revenue by Type (2018-2034)
7.3 Europe Pentavalent Antimonials Market Size by Application
7.3.1 Europe Pentavalent Antimonials Sales Quantity by Application (2018-2034)
7.3.2 Europe Pentavalent Antimonials Revenue by Application (2018-2034)
7.4 Europe Pentavalent Antimonials Market Size by Country
7.4.1 Europe Pentavalent Antimonials Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Pentavalent Antimonials Revenue by Country (2018-2034)
7.4.3 Europe Pentavalent Antimonials Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Pentavalent Antimonials Sales by Company
8.1.1 China Pentavalent Antimonials Sales Quantity by Company (2018-2024)
8.1.2 China Pentavalent Antimonials Revenue by Company (2018-2024)
8.2 China Pentavalent Antimonials Market Size by Type
8.2.1 China Pentavalent Antimonials Sales Quantity by Type (2018-2034)
8.2.2 China Pentavalent Antimonials Revenue by Type (2018-2034)
8.3 China Pentavalent Antimonials Market Size by Application
8.3.1 China Pentavalent Antimonials Sales Quantity by Application (2018-2034)
8.3.2 China Pentavalent Antimonials Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Pentavalent Antimonials Sales by Company
9.1.1 APAC Pentavalent Antimonials Sales Quantity by Company (2018-2024)
9.1.2 APAC Pentavalent Antimonials Revenue by Company (2018-2024)
9.2 APAC Pentavalent Antimonials Market Size by Type
9.2.1 APAC Pentavalent Antimonials Sales Quantity by Type (2018-2034)
9.2.2 APAC Pentavalent Antimonials Revenue by Type (2018-2034)
9.3 APAC Pentavalent Antimonials Market Size by Application
9.3.1 APAC Pentavalent Antimonials Sales Quantity by Application (2018-2034)
9.3.2 APAC Pentavalent Antimonials Revenue by Application (2018-2034)
9.4 APAC Pentavalent Antimonials Market Size by Region
9.4.1 APAC Pentavalent Antimonials Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Pentavalent Antimonials Revenue by Region (2018-2034)
9.4.3 APAC Pentavalent Antimonials Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pentavalent Antimonials Sales by Company
10.1.1 Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Pentavalent Antimonials Market Size by Type
10.2.1 Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Pentavalent Antimonials Market Size by Application
10.3.1 Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Pentavalent Antimonials Market Size by Country
10.4.1 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Pentavalent Antimonials Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Sanofi Pentavalent Antimonials Products and Services
11.1.5 Sanofi Pentavalent Antimonials SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Pentavalent Antimonials Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 GlaxoSmithKline Pentavalent Antimonials Products and Services
11.2.5 GlaxoSmithKline Pentavalent Antimonials SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Pentavalent Antimonials Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Bristol-Myers Squibb Pentavalent Antimonials Products and Services
11.3.5 Bristol-Myers Squibb Pentavalent Antimonials SWOT Analysis
11.3.6 Bristol-Myers Squibb Recent Developments
11.4 Maiden Pharmaceuticals
11.4.1 Maiden Pharmaceuticals Company Information
11.4.2 Maiden Pharmaceuticals Overview
11.4.3 Maiden Pharmaceuticals Pentavalent Antimonials Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Maiden Pharmaceuticals Pentavalent Antimonials Products and Services
11.4.5 Maiden Pharmaceuticals Pentavalent Antimonials SWOT Analysis
11.4.6 Maiden Pharmaceuticals Recent Developments
11.5 Xinhua Pharm
11.5.1 Xinhua Pharm Company Information
11.5.2 Xinhua Pharm Overview
11.5.3 Xinhua Pharm Pentavalent Antimonials Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Xinhua Pharm Pentavalent Antimonials Products and Services
11.5.5 Xinhua Pharm Pentavalent Antimonials SWOT Analysis
11.5.6 Xinhua Pharm Recent Developments
11.6 Albert David
11.6.1 Albert David Company Information
11.6.2 Albert David Overview
11.6.3 Albert David Pentavalent Antimonials Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Albert David Pentavalent Antimonials Products and Services
11.6.5 Albert David Pentavalent Antimonials SWOT Analysis
11.6.6 Albert David Recent Developments
11.7 Science Direct
11.7.1 Science Direct Company Information
11.7.2 Science Direct Overview
11.7.3 Science Direct Pentavalent Antimonials Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Science Direct Pentavalent Antimonials Products and Services
11.7.5 Science Direct Pentavalent Antimonials SWOT Analysis
11.7.6 Science Direct Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pentavalent Antimonials Value Chain Analysis
12.2 Pentavalent Antimonials Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pentavalent Antimonials Production Mode & Process
12.4 Pentavalent Antimonials Sales and Marketing
12.4.1 Pentavalent Antimonials Sales Channels
12.4.2 Pentavalent Antimonials Distributors
12.5 Pentavalent Antimonials Customers
13 Market Dynamics
13.1 Pentavalent Antimonials Industry Trends
13.2 Pentavalent Antimonials Market Drivers
13.3 Pentavalent Antimonials Market Challenges
13.4 Pentavalent Antimonials Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pentavalent Antimonials Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Sodium Stibogluconate
Table 3. Major Manufacturers of Meglumine Antimoniate
Table 4. Global Pentavalent Antimonials Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Pentavalent Antimonials Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Pentavalent Antimonials Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Pentavalent Antimonials Revenue Market Share by Region (2018-2024)
Table 8. Global Pentavalent Antimonials Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Pentavalent Antimonials Revenue Market Share by Region (2024-2034)
Table 10. Global Pentavalent Antimonials Sales Quantity by Region: 2018 VS 2022 VS 2034 (g)
Table 11. Global Pentavalent Antimonials Sales by Region (2018-2024) & (g)
Table 12. Global Pentavalent Antimonials Sales Market Share by Region (2018-2024)
Table 13. Global Pentavalent Antimonials Sales by Region (2024-2034) & (g)
Table 14. Global Pentavalent Antimonials Sales Market Share by Region (2024-2034)
Table 15. Global Pentavalent Antimonials Sales Quantity by Manufacturers (2018-2024) & (g)
Table 16. Global Pentavalent Antimonials Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Pentavalent Antimonials Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Pentavalent Antimonials Revenue Share by Manufacturers (2018-2024)
Table 19. Global Pentavalent Antimonials Price by Manufacturers 2018-2024 (USD/mg)
Table 20. Global Key Players of Pentavalent Antimonials, Industry Ranking, 2021 VS 2022
Table 21. Global Pentavalent Antimonials Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pentavalent Antimonials by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pentavalent Antimonials as of 2022)
Table 23. Global Key Manufacturers of Pentavalent Antimonials, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pentavalent Antimonials, Product Offered and Application
Table 25. Global Key Manufacturers of Pentavalent Antimonials, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pentavalent Antimonials Sales Quantity by Type (2018-2024) & (g)
Table 28. Global Pentavalent Antimonials Sales Quantity by Type (2024-2034) & (g)
Table 29. Global Pentavalent Antimonials Sales Quantity Share by Type (2018-2024)
Table 30. Global Pentavalent Antimonials Sales Quantity Share by Type (2024-2034)
Table 31. Global Pentavalent Antimonials Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Pentavalent Antimonials Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Pentavalent Antimonials Revenue Share by Type (2018-2024)
Table 34. Global Pentavalent Antimonials Revenue Share by Type (2024-2034)
Table 35. Pentavalent Antimonials Price by Type (2018-2024) & (USD/mg)
Table 36. Global Pentavalent Antimonials Price Forecast by Type (2024-2034) & (USD/mg)
Table 37. Global Pentavalent Antimonials Sales Quantity by Application (2018-2024) & (g)
Table 38. Global Pentavalent Antimonials Sales Quantity by Application (2024-2034) & (g)
Table 39. Global Pentavalent Antimonials Sales Quantity Share by Application (2018-2024)
Table 40. Global Pentavalent Antimonials Sales Quantity Share by Application (2024-2034)
Table 41. Global Pentavalent Antimonials Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Pentavalent Antimonials Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Pentavalent Antimonials Revenue Share by Application (2018-2024)
Table 44. Global Pentavalent Antimonials Revenue Share by Application (2024-2034)
Table 45. Pentavalent Antimonials Price by Application (2018-2024) & (USD/mg)
Table 46. Global Pentavalent Antimonials Price Forecast by Application (2024-2034) & (USD/mg)
Table 47. North America Pentavalent Antimonials Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Pentavalent Antimonials Sales Quantity by Company (2018-2024) & (g)
Table 49. North America Pentavalent Antimonials Sales Quantity by Type (2018-2024) & (g)
Table 50. North America Pentavalent Antimonials Sales Quantity by Type (2024-2034) & (g)
Table 51. North America Pentavalent Antimonials Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Pentavalent Antimonials Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Pentavalent Antimonials Sales Quantity by Application (2018-2024) & (g)
Table 54. North America Pentavalent Antimonials Sales Quantity by Application (2024-2034) & (g)
Table 55. North America Pentavalent Antimonials Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Pentavalent Antimonials Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Pentavalent Antimonials Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Pentavalent Antimonials Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Pentavalent Antimonials Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Pentavalent Antimonials Sales Quantity by Country (2018-2024) & (g)
Table 61. North America Pentavalent Antimonials Sales Quantity by Country (2024-2034) & (g)
Table 62. Europe Pentavalent Antimonials Sales Quantity by Company (2018-2024) & (g)
Table 63. Europe Pentavalent Antimonials Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Pentavalent Antimonials Sales Quantity by Type (2018-2024) & (g)
Table 65. Europe Pentavalent Antimonials Sales Quantity by Type (2024-2034) & (g)
Table 66. Europe Pentavalent Antimonials Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Pentavalent Antimonials Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Pentavalent Antimonials Sales Quantity by Application (2018-2024) & (g)
Table 69. Europe Pentavalent Antimonials Sales Quantity by Application (2024-2034) & (g)
Table 70. Europe Pentavalent Antimonials Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Pentavalent Antimonials Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Pentavalent Antimonials Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Pentavalent Antimonials Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Pentavalent Antimonials Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Pentavalent Antimonials Sales Quantity by Country (2018-2024) & (g)
Table 76. Europe Pentavalent Antimonials Sales Quantity by Country (2024-2034) & (g)
Table 77. China Pentavalent Antimonials Sales Quantity by Company (2018-2024) & (g)
Table 78. China Pentavalent Antimonials Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Pentavalent Antimonials Sales Quantity by Type (2018-2024) & (g)
Table 80. China Pentavalent Antimonials Sales Quantity by Type (2024-2034) & (g)
Table 81. China Pentavalent Antimonials Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Pentavalent Antimonials Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Pentavalent Antimonials Sales Quantity by Application (2018-2024) & (g)
Table 84. China Pentavalent Antimonials Sales Quantity by Application (2024-2034) & (g)
Table 85. China Pentavalent Antimonials Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Pentavalent Antimonials Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Pentavalent Antimonials Sales Quantity by Company (2018-2024) & (g)
Table 88. APAC Pentavalent Antimonials Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Pentavalent Antimonials Sales Quantity by Type (2018-2024) & (g)
Table 90. APAC Pentavalent Antimonials Sales Quantity by Type (2024-2034) & (g)
Table 91. APAC Pentavalent Antimonials Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Pentavalent Antimonials Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Pentavalent Antimonials Sales Quantity by Application (2018-2024) & (g)
Table 94. APAC Pentavalent Antimonials Sales Quantity by Application (2024-2034) & (g)
Table 95. APAC Pentavalent Antimonials Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Pentavalent Antimonials Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Pentavalent Antimonials Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Pentavalent Antimonials Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Pentavalent Antimonials Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Pentavalent Antimonials Sales Quantity by Region (2018-2024) & (g)
Table 101. APAC Pentavalent Antimonials Sales Quantity by Region (2024-2034) & (g)
Table 102. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Company (2018-2024) & (g)
Table 103. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Type (2018-2024) & (g)
Table 105. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Type (2024-2034) & (g)
Table 106. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Application (2018-2024) & (g)
Table 109. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Application (2024-2034) & (g)
Table 110. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Pentavalent Antimonials Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Country (2018-2024) & (g)
Table 116. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity by Country (2024-2034) & (g)
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Overview
Table 119. Sanofi Pentavalent Antimonials Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2018-2024)
Table 120. Sanofi Pentavalent Antimonials Product and Services
Table 121. Sanofi Pentavalent Antimonials SWOT Analysis
Table 122. Sanofi Recent Developments
Table 123. GlaxoSmithKline Company Information
Table 124. GlaxoSmithKline Description and Overview
Table 125. GlaxoSmithKline Pentavalent Antimonials Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2018-2024)
Table 126. GlaxoSmithKline Pentavalent Antimonials Product and Services
Table 127. GlaxoSmithKline Pentavalent Antimonials SWOT Analysis
Table 128. GlaxoSmithKline Recent Developments
Table 129. Bristol-Myers Squibb Company Information
Table 130. Bristol-Myers Squibb Description and Overview
Table 131. Bristol-Myers Squibb Pentavalent Antimonials Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2018-2024)
Table 132. Bristol-Myers Squibb Pentavalent Antimonials Product and Services
Table 133. Bristol-Myers Squibb Pentavalent Antimonials SWOT Analysis
Table 134. Bristol-Myers Squibb Recent Developments
Table 135. Maiden Pharmaceuticals Company Information
Table 136. Maiden Pharmaceuticals Description and Overview
Table 137. Maiden Pharmaceuticals Pentavalent Antimonials Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2018-2024)
Table 138. Maiden Pharmaceuticals Pentavalent Antimonials Product and Services
Table 139. Maiden Pharmaceuticals Pentavalent Antimonials SWOT Analysis
Table 140. Maiden Pharmaceuticals Recent Developments
Table 141. Xinhua Pharm Company Information
Table 142. Xinhua Pharm Description and Overview
Table 143. Xinhua Pharm Pentavalent Antimonials Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2018-2024)
Table 144. Xinhua Pharm Pentavalent Antimonials Product and Services
Table 145. Xinhua Pharm Pentavalent Antimonials SWOT Analysis
Table 146. Xinhua Pharm Recent Developments
Table 147. Albert David Company Information
Table 148. Albert David Description and Overview
Table 149. Albert David Pentavalent Antimonials Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2018-2024)
Table 150. Albert David Pentavalent Antimonials Product and Services
Table 151. Albert David Pentavalent Antimonials SWOT Analysis
Table 152. Albert David Recent Developments
Table 153. Science Direct Company Information
Table 154. Science Direct Description and Overview
Table 155. Science Direct Pentavalent Antimonials Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2018-2024)
Table 156. Science Direct Pentavalent Antimonials Product and Services
Table 157. Science Direct Pentavalent Antimonials SWOT Analysis
Table 158. Science Direct Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Pentavalent Antimonials Distributors List
Table 162. Pentavalent Antimonials Customers List
Table 163. Pentavalent Antimonials Market Trends
Table 164. Pentavalent Antimonials Market Drivers
Table 165. Pentavalent Antimonials Market Challenges
Table 166. Pentavalent Antimonials Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Pentavalent Antimonials Product Picture
Figure 2. Global Pentavalent Antimonials Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pentavalent Antimonials Market Share by Type in 2022 & 2034
Figure 4. Sodium Stibogluconate Product Picture
Figure 5. Meglumine Antimoniate Product Picture
Figure 6. Global Pentavalent Antimonials Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Pentavalent Antimonials Market Share by Application in 2022 & 2034
Figure 8. Hospitals Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Pentavalent Antimonials Report Years Considered
Figure 12. Global Pentavalent Antimonials Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Pentavalent Antimonials Revenue 2018-2034 (US$ Million)
Figure 14. Global Pentavalent Antimonials Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Pentavalent Antimonials Sales Quantity 2018-2034 (g)
Figure 16. Global Pentavalent Antimonials Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Pentavalent Antimonials Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Pentavalent Antimonials Sales Quantity YoY (2018-2034) & (g)
Figure 19. North America Pentavalent Antimonials Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Pentavalent Antimonials Sales Quantity YoY (2018-2034) & (g)
Figure 21. Europe Pentavalent Antimonials Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Pentavalent Antimonials Sales Quantity YoY (2018-2034) & (g)
Figure 23. China Pentavalent Antimonials Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Pentavalent Antimonials Sales Quantity YoY (2018-2034) & (g)
Figure 25. APAC Pentavalent Antimonials Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity YoY (2018-2034) & (g)
Figure 27. Middle East, Africa and Latin America Pentavalent Antimonials Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Pentavalent Antimonials Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Pentavalent Antimonials Revenue in 2022
Figure 30. Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Pentavalent Antimonials Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Pentavalent Antimonials Revenue Market Share by Type (2018-2034)
Figure 33. Global Pentavalent Antimonials Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Pentavalent Antimonials Revenue Market Share by Application (2018-2034)
Figure 35. North America Pentavalent Antimonials Revenue Market Share by Company in 2022
Figure 36. North America Pentavalent Antimonials Sales Quantity Market Share by Company in 2022
Figure 37. North America Pentavalent Antimonials Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Pentavalent Antimonials Revenue Market Share by Type (2018-2034)
Figure 39. North America Pentavalent Antimonials Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Pentavalent Antimonials Revenue Market Share by Application (2018-2034)
Figure 41. North America Pentavalent Antimonials Revenue Share by Country (2018-2034)
Figure 42. North America Pentavalent Antimonials Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Pentavalent Antimonials Sales Quantity Market Share by Company in 2022
Figure 46. Europe Pentavalent Antimonials Revenue Market Share by Company in 2022
Figure 47. Europe Pentavalent Antimonials Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Pentavalent Antimonials Revenue Market Share by Type (2018-2034)
Figure 49. Europe Pentavalent Antimonials Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Pentavalent Antimonials Revenue Market Share by Application (2018-2034)
Figure 51. Europe Pentavalent Antimonials Revenue Share by Country (2018-2034)
Figure 52. Europe Pentavalent Antimonials Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 54. France Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 58. China Pentavalent Antimonials Sales Quantity Market Share by Company in 2022
Figure 59. China Pentavalent Antimonials Revenue Market Share by Company in 2022
Figure 60. China Pentavalent Antimonials Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Pentavalent Antimonials Revenue Market Share by Type (2018-2034)
Figure 62. China Pentavalent Antimonials Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Pentavalent Antimonials Revenue Market Share by Application (2018-2034)
Figure 64. APAC Pentavalent Antimonials Sales Quantity Market Share by Company in 2022
Figure 65. APAC Pentavalent Antimonials Revenue Market Share by Company in 2022
Figure 66. APAC Pentavalent Antimonials Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Pentavalent Antimonials Revenue Market Share by Type (2018-2034)
Figure 68. APAC Pentavalent Antimonials Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Pentavalent Antimonials Revenue Market Share by Application (2018-2034)
Figure 70. APAC Pentavalent Antimonials Revenue Share by Region (2018-2034)
Figure 71. APAC Pentavalent Antimonials Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 76. India Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Pentavalent Antimonials Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Pentavalent Antimonials Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Pentavalent Antimonials Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Pentavalent Antimonials Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Pentavalent Antimonials Revenue Share by Country (2018-2034)
Figure 85. Brazil Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Pentavalent Antimonials Revenue (2018-2034) & (US$ Million)
Figure 90. Pentavalent Antimonials Value Chain
Figure 91. Pentavalent Antimonials Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed